IDXX · 8-K · 20260804PR090033

Liquidity and Debt Position

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 81 · Surprise 64 · No source text

Cash and cash equivalents increased to $196.9 million at June 30, 2026 from $180.1 million at December 31, 2025. The line of credit increased to $519.0 million from $398.0 million, while current long-term debt increased to $150.0 million from $75.0 million. Long-term debt, net of the current portion, declined to $299.9 million from $374.8 million. Six-month net borrowings under the credit facility were $121.0 million, compared with $329.0 million in the prior-year period.

Key facts

• Net interest expense projected for 2026: ~ $35 (prior ~ $34). source
• Current portion of long-term debt as of June 30, 2026: $149,999; long-term debt, net of current portion: $299,865. source
• Line of credit balance as of June 30, 2026: $519,000 (current liability). source
• Borrowings under credit facility, net for six months ended June 30, 2026: $121,000 (financing cash flow). source
• Cash and cash equivalents as of June 30, 2026: $196,933, compared to $180,070 as of December 31, 2025. source
• Inventory turns for June 30, 2026: 1.4 (compared to 1.6 on December 31, 2025). source
• Days sales outstanding as of June 30, 2026: 46.2 days (same as March 31, 2026). source

Impact estimates